SCHEMBL2014242

SCHEMBL2014242

CCCCCCCCCCCC(=O)OCCC(O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.71
MAPT P10636 1/20 0.61
DNM1 Q05193 1/20 0.59
LMNA P02545 4/20 0.57
KDM4E B2RXH2 1/20 0.57
DUSP3 P51452 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
PAM P19021 2/20 0.55
ALDH1A1 P00352 1/20 0.54
TSHR P16473 1/20 0.51
PRSS1 P07477 1/20 0.51
PRSS2 P07478 1/20 0.51
PRSS3 P35030 1/20 0.51
LPAR6 P43657 1/20 0.50
LPAR1 Q92633 1/20 0.50
LPAR4 Q99677 1/20 0.50
LPAR5 Q9H1C0 1/20 0.50
LPAR2 Q9HBW0 1/20 0.50
LPAR3 Q9UBY5 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7054539 1.00 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL7549031 1.00 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL7048642 1.00 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL7052207 0.98 DGKA (0.68) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL35584 0.87 DGKA (0.69) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL2864987 0.87 DGKA (0.69) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL8730928 0.87 DGKA (0.69) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL19409845 0.85 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL2397395 0.85 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E
SCHEMBL120186 0.85 DGKA (0.71) DGKAMAPTDNM1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117460524-A Transdermal insulin formulations and methods of use thereof 透皮给药解决方案公司(DBA无针注射器医药) 2024-01-26 CN claimed
US-20230149309-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-05-18 US claimed
EP-4117633-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2023-01-18 EP claimed
WO-2021191462-A1 COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES SHARED VISION TECHNOLOGY LTD. (IE) 2021-09-30 WO claimed
CN-106243415-B A kind of store method of natural emulsion and obtained latex product 济南圣泉集团股份有限公司 2017-11-24 CN claimed
EP-4681738-A1 1,4-POLYISOPRENE DISPERSION SYSTEM, PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF Suzhou Haiyi Biomedical Technology Co., Ltd (CN) 2026-01-21 EP disclosed
CN-119112780-A 1, 4-Polyisoprene dispersion system, pharmaceutical active ingredient and application thereof 苏州海益生物医药科技有限公司 2024-12-13 CN disclosed
CN-117460524-A Transdermal insulin formulations and methods of use thereof 透皮给药解决方案公司(DBA无针注射器医药) 2024-01-26 CN disclosed
CN-110177536-B Barrier patch with dissolvable film and method of improving skin appearance 宝洁公司 2024-01-02 CN disclosed
CN-117119897-A Use of gossypol and methane inhibitors for reducing the formation of methane resulting from digestive activities of ruminants 帝斯曼知识产权资产管理有限公司 2023-11-24 CN disclosed
CN-111698984-B Method for preparing barrier patch with soluble film 宝洁公司 2023-11-14 CN disclosed
CN-116271061-A 1, 4-polyisoprene dispersion system, pharmaceutical active ingredient and application thereof 苏州海益生物医药科技有限公司 2023-06-23 CN disclosed
CN-106243415-B A kind of store method of natural emulsion and obtained latex product 济南圣泉集团股份有限公司 2017-11-24 CN disclosed
CN-106243415-A The store method of a kind of natural emulsion and prepared latex product 济南圣泉集团股份有限公司 2016-12-21 CN disclosed
CN-105504342-A Application of graphene in natural latex preservation and latex product JINAN SHENGQUAN GROUP SHARE-HOLDING CO LTD 2016-04-20 CN disclosed
CN-103974937-A Novel adipogenesis inhibitor compounds FABRE PIERRE DERMO COSMETIQUE 2014-08-06 CN disclosed
EP-2512420-A2 USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA Pierre Fabre Dermo-Cosmétique (FR) 2012-10-24 EP disclosed
WO-2011073370-A2 USE OF 2,3-DIHYDROXYPROPYL DODECANOATE FOR TREATING SEBORRHEA PIERRE FABRE DERMO-COSMETIQUE (FR) 2011-06-23 WO disclosed
CN-1108830-C Wound dressing with improved water vapor permeability and reduced trauma MINNESOTA MINING & MFG (US) 2003-05-21 CN disclosed
CN-1162268-A Low trauma wound dressing with improved moisture vapor permeability MINNESOTA MINING & MFG (US) 1997-10-15 CN disclosed